Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Generon (Shanghai) Corp. Ltd.
DescriptionRecombinant protein containing a human interleukin-22 (IL-22) dimer
Molecular Target Interleukin-22 (IL-22)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today